Model-based design of the first steps of a seed train for cell culture processes
© Kern et al.; licensee BioMed Central Ltd. 2013
Published: 4 December 2013
Production of biopharmaceuticals for diagnostic and therapeutic applications with suspension cells in bioreactors requires a seed train up to production scale . For the final process steps in pilot and production scale the scale-up steps are usually defined (e.g. a factor of 5 - 10). More difficult in this respect are the first steps, the transitions between T-flasks, spinner tubes, roller bottles, shake flasks, stirred bioreactors or single-use reactors, because here often scale-up steps are different. The experimental effort to lay these steps out is correspondingly high. At the same time it is known that the first cultivation steps have a significant impact on the success or failure on production scale. The concept for a model based design of the seed train consists of the following steps:
➢ A simple unstructured kinetic model, where kinetic parameters can be obtained from a few experiments only.
➢ A Nelder-Mead-algorithm to determine model parameters.
➢ A MATLAB simulation based on this model to determine optimal points in time or viable cell concentrations respectively for harvest of seed train scales from spinner tubes over shake flasks up to a stirred bioreactor based on an optimization criterion.
The concept was verified for a suspendable cell line (AGE1.HN, ProBioGen AG) grown in serum-free 42-Max-UB medium (Teutocell AG, Germany) containing 5 mM-Glutamine.
Two batch experiments were performed in shake flasks for determination of kinetic parameters.
The average value of time for minimal and maximal Space-Time-Yield for cells was used as optimization criterion for cell transfer.
The concept offers a simple and inexpensive strategy for design of the first scale-up steps. The results show that the tool was able to perform a seed train optimization only on the basis of two batches, the underlying model and its parameter identification. This quick optimization led to the same results as the extensive manual optimization carried out in the past.
The bioreactor (Labfors 5 Cell) was kindly provided by the company Infors AG, the cell line AGE1.HN by ProBioGen AG.
- Eibl R, Eibl D, Pörtner R, Catapano G, Czermak P: Cell and Tissue Reaction Engineering. Springer. 2008, ISBN 978-3-540-68175-5Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.